NCT06715384 Evaluation of a CAM System for Colorectal Polyp Size Measurement
| NCT ID | NCT06715384 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Changhai Hospital |
| Condition | Colorectal Polyp |
| Study Type | INTERVENTIONAL |
| Enrollment | 168 participants |
| Start Date | 2024-12-15 |
| Primary Completion | 2025-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 168 participants in total. It began in 2024-12-15 with a primary completion date of 2025-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Accurate polyp size measurements are essential for risk stratification, selection of polypectomy techniques, and surveillance interval assignments. Evidence indicated that the clinical implementation of artificial intelligence is an optimal tool to improve the measurement of polyps during colonoscopy. This study aimed to evaluate the performance of a computer-aided measuring (CAM) system (EndoDASS) and compare its accuracy with routine sizing methods during real-time colonoscopy.
Eligibility Criteria
Inclusion Criteria: 1. Adults aged 18-75, any gender; 76-85 years eligible case-by-case based on health status. 2. Colonoscopy screening, surveillance, or diagnostic participants. 3. Informed consent obtained. Exclusion Criteria: 1. Anticoagulant use (e.g., aspirin, warfarin) within 7 days prior to colonoscopy or coagulopathy. 2. Inflammatory bowel disease. 3. Aronchick score \>3 at entry. 4. Incomplete Case Report Form (CRF) data. 5. Emergency colonoscopy. 6. Pregnancy or lactation. 7. Gastrointestinal obstruction. 8. Refusal to participate.
Contact & Investigator
Sheng-Bing Zhao, MD
PRINCIPAL INVESTIGATOR
Department of Gastroenterology, National Clinical Research Center for Digestive Diseases, Changhai Hospital, Naval Medical University, Shanghai 200433, China.
Frequently Asked Questions
Who can join the NCT06715384 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Colorectal Polyp. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06715384 currently recruiting?
Yes, NCT06715384 is actively recruiting participants. Contact the research team at sunshinewangcl@126.com for enrollment information.
Where is the NCT06715384 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT06715384 clinical trial?
NCT06715384 is sponsored by Changhai Hospital. The principal investigator is Sheng-Bing Zhao, MD at Department of Gastroenterology, National Clinical Research Center for Digestive Diseases, Changhai Hospital, Naval Medical University, Shanghai 200433, China.. The trial plans to enroll 168 participants.